SavedAdd your journal

Journals / Kocaeli Üniversitesi Sağlık Bilimleri Dergisi / 2020 / Cilt: 6 - Sayı: 3

DRUGS USED IN THE TREATMENT OF CORONAVIRUS DISESASE (COVID-19)

KORONAVİRÜS HASTALIĞI (COVID-19) TEDAVİSİNDE KULLANILAN İLAÇLAR

Oguz Mutlu
İbrahim Uygun
Bekir Faruk Erden
Pages
168–173
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Drugs having efficacy against SARS-CoV-2 are summarised in this article.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:SARS-CoV-2 virus appeared in December 2019 and at the beginning spread in China, Japan, and South Korea, then all around the world.
📊
Key Findings & Data:Hydroxychloroquine, azithromycin, favipiravir, remdesivir, lopinavir/ritonavir tried to be used in the treatment of coronavirus disease 2019 (COVID-19).
💡
Conclusion & Impact:Drugs having efficacy against SARS-CoV-2 are summarised in this article.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

SARS-CoV-2 virus appeared in December 2019 and at the beginning spread in China, Japan, and South Korea, then all around the world. Scientists are trying to find specific antiviral to the virus. Hydroxychloroquine, azithromycin, favipiravir, remdesivir, lopinavir/ritonavir tried to be used in the treatment of coronavirus disease 2019 (COVID-19). These drugs are still in clinical trials in the world and there are some promising results. Drugs having efficacy against SARS-CoV-2 are summarised in this article.

Özet

SARS-CoV-2 virüsü Aralık 2019’da ortaya çıkmış ve başlangıçta Çin, Japonya ve Güney Kore olmak üzere tüm dünyada hızlıca yayılmıştır. Biliminsanları virüse spesifik antiviral bulmak için çabalamaktadır. Koronavirüs hastalığı 2019 (COVID-19) tedavisinde hidroksiklorokin, azitromisin,favipiravir, remdesivir, lopinavir/ritonavir gibi ilaçlar denenmektedir. Dünyada bu ilaçlar halen klinik çalışmalardan geçmektedir, bazı umut verensonuçlara ulaşılmıştır. Bu makalede SARS-CoV-2’ye karşı güçlü etkinliği olan ilaçlar özetlenmektedir.

🔖

Cite This Article

Mutlu, O., Uygun, İ., Erden, B. F. (2022). DRUGS USED IN THE TREATMENT OF CORONAVIRUS DISESASE (COVID-19). Kocaeli Üniversitesi Sağlık Bilimleri Dergisi, Cilt: 6 - Sayı: 3, 168–173. https://ajindex.com/articles/575051

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Guidelines for the Prevention, Diagnosis, and Treatment of Novel Coronavirus-induced Pneumonia, The 5th ed. http://www.nhc.gov.cn/yzygj/s7653p/202002/d4b895337e1944 5f8d728fcaf1e3e13a/files/ab6bec7f93e64e7f998d802991203c d6.pdf (Erişim Tarihi: 18.02.2020). (in Chinese)
  2. McCreary EK, Pogue JM. Coronavirus disease 2019 treatment: a review of early and emerging options. Open Forum Infect. Dis. 2020; 7(4): ofaa105. doi: 10.1093/ofid/ofaa105 3. Kalil AC. Treating COVID-19–Off-Label Drug Use,Compassionate Use, and Randomized Clinical Trials DuringPandemics. JAMA 2020. doi: 10.1001/jama.2020.4742 4. Uyeki TM, Bernstein HH, Bradley JS et al. Clinical practice guidelines by the infectious diseasessociety of America: 2018 update on diagnosis, treatment,chemoprophylaxis, and institutional outbreak management ofseasonal influenzaa. Clin. Infect. Dis. 2019; 68: e1.doi: 10.1093/cid/ciy866 5. Chan KS. Treatment of severe acute respiratory syndrome withlopinavir/ritonavir: a multicentre retrospective matched cohort study. Hong Kong Med. J. 2003; 9: 399-406
  3. Guidelines for the Prevention, Diagnosis, and Treatment of Novel Coronavirus-induced Pneumonia, The 6th ed. http:// www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326d d94d329df351d7da8aefc2/files/b218cfeb1bc54639af227f9 22bf6b817.pdf (accessed February 23, 2020). (in Chinese)
  4. Stockman LJ, Bellamy R, Garner P. SARS: Systematic review of treatment effects. PLoS Med. 2006; 3:e343
  5. Su B, Wang Y, Zhou R et al. Efficacy and tolerability of lopinavir/ritonavir- and efavirenz-based initial antiretroviral therapy in HIV-1- infected patients in a tertiary care hospital in Beijing, China. Front Pharmacol. 2019; 10:1472
  6. Chu CM, Cheng VCC, Hung IFN et al. Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings. Thorax. 2004; 59:252-256
  7. Savarino A, Di Trani L, Donatelli I et al. New insights into the antiviral effects of chloroquine. Lancet Infect Dis. 2006;6:67-69
  8. Wang M, Cao R, Zhang L et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020
  9. News: Abidol and darunavir can effectively inhibit coronavirus http://www.sd.chinanews. com/2/2020/0205/70145.html (accessed February 21, 2020). (in Chinese)
  10. Delang L, Abdelnabi R, Neyts J. Favipiravir as a potential countermeasure against neglected and emerging RNA viruses. Antiviral Res. 2018;153:85-94
  11. Furuta Y, Komeno T, Nakamura T. Favipir